312 related articles for article (PubMed ID: 29530841)
1. TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
Enosi Tuipulotu D; Netzler NE; Lun JH; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530841
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.
Ng YC; Kim YW; Lee JS; Lee SJ; Jung Song M
J Microbiol; 2018 Sep; 56(9):683-689. PubMed ID: 30141161
[TBL] [Abstract][Full Text] [Related]
3. The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.
Enosi Tuipulotu D; Fumian TM; Netzler NE; Mackenzie JM; White PA
Viruses; 2019 May; 11(6):. PubMed ID: 31151251
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of TLR7 exerts inhibition on the replication of EV-D68 in respiratory cells.
Li H; Huang Y; Yang Q; Zhang Z; Shen S; Guo H; Wei W
J Virol; 2024 Jun; 98(6):e0043424. PubMed ID: 38690875
[TBL] [Abstract][Full Text] [Related]
5. The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model.
Rocha-Pereira J; Jochmans D; Debing Y; Verbeken E; Nascimento MS; Neyts J
J Virol; 2013 Nov; 87(21):11798-805. PubMed ID: 23986582
[TBL] [Abstract][Full Text] [Related]
6. Activating the innate immune response to counter chronic hepatitis B virus infection.
Lamb C; Arbuthnot P
Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
[TBL] [Abstract][Full Text] [Related]
7. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
[TBL] [Abstract][Full Text] [Related]
8. Antiviral efficacy of orally delivered neoagarohexaose, a nonconventional TLR4 agonist, against norovirus infection in mice.
Kim M; Lee JE; Cho H; Jung HG; Lee W; Seo HY; Lee SH; Ahn DG; Kim SJ; Yu JW; Oh JW
Biomaterials; 2020 Dec; 263():120391. PubMed ID: 32977259
[TBL] [Abstract][Full Text] [Related]
9. Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.
Eltahla AA; Lim KL; Eden JS; Kelly AG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2014 Jun; 58(6):3115-23. PubMed ID: 24637690
[TBL] [Abstract][Full Text] [Related]
10. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.
Buitendijk M; Eszterhas SK; Howell AL
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):907-18. PubMed ID: 23316755
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome.
Lee H; Ko G
Sci Rep; 2016 May; 6():25835. PubMed ID: 27180604
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
[TBL] [Abstract][Full Text] [Related]
13. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
14. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic efficacy of orally administered Bacillus poly-γ-glutamic acid, a non-LPS TLR4 ligand, against norovirus infection in mice.
Lee W; Kim M; Lee SH; Jung HG; Oh JW
Sci Rep; 2018 Jun; 8(1):8667. PubMed ID: 29875467
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis Is an Intrinsic Factor for Optimal Replication of a Norovirus.
Passalacqua KD; Lu J; Goodfellow I; Kolawole AO; Arche JR; Maddox RJ; Carnahan KE; O'Riordan MXD; Wobus CE
mBio; 2019 Mar; 10(2):. PubMed ID: 30862747
[TBL] [Abstract][Full Text] [Related]
17. Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis.
Thorne L; Arias A; Goodfellow I
J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S27-31. PubMed ID: 26744429
[TBL] [Abstract][Full Text] [Related]
18. 2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
Yu P; Wang Y; Li Y; Li Y; Miao Z; Peppelenbosch MP; Pan Q
Arch Virol; 2020 Nov; 165(11):2605-2613. PubMed ID: 32770483
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Shows Antiviral Properties against Norovirus.
Yang M; Lee G; Si J; Lee SJ; You HJ; Ko G
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775614
[TBL] [Abstract][Full Text] [Related]
20. Norovirus: targets and tools in antiviral drug discovery.
Rocha-Pereira J; Neyts J; Jochmans D
Biochem Pharmacol; 2014 Sep; 91(1):1-11. PubMed ID: 24893351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
